Dr. Skoulidis chats with Terri Conneran, a stage 3 lung cancer patient with a KRAS mutation, about treatment strategies and options. They discuss adagrasib and sotorasib, new clinical trials, and the significance of KRAS G12C, G12D, G12S mutations. Topics covered include STK11, KEAP1, CtDNA, liquid biopsy, stable disease, and combination therapies.
Dr. Ferdinandos Skoulidis, an Associate Professor at The University of Texas MD Anderson Cancer Center, brings his expertise in thoracic/head and neck medical oncology to the conversation. Terri Conneran, a KRAS G12D lung cancer patient of six years, seeks answers to make the best choices for her treatment journey.
KRASKickers.org serves as an online community, connecting cancer patients and advocating for KRAS knowledge, research, and survivorship. Together, they aim to kick cancer's KRAS through shared support and resources.
The American Association for Cancer Research (AACR.org) organizes an annual research conference. The April 2023 conference featured extensive updates on KRAS mutation data, providing valuable insights for patients and healthcare professionals alike.
Join the KRASKickers.org community and learn about KRAS cancers. Together, they strive to overcome the challenges posed by KRAS mutations. It's a collective effort to kick cancer's KRAS!
KRASKickers.org
Are you KRAS Wild or KRAS Mutant? Don't hesitate to ask your healthcare provider. By understanding your KRAS status, you can make informed decisions about your cancer treatment journey.
28 сен 2024
